Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Thornton

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1980
Carbenoxolone interactions in man--preliminary reportP C Thornton, M Papouchado, P I Reed
Laboratory Animals|April 1, 1979
The ferret, Mustela putorius furo, as a new species in toxicologyP C Thornton, P A Wright, P J Sacra, et al.
Plos Genetics|April 11, 2006
On the mechanism of gene amplification induced under stress in Escherichia coliAndrew Slack, P C Thornton, Daniel B Magner, et al.
Annals of the New York Academy of Sciences|September 8, 2012
Gross chromosomal rearrangement mediated by DNA replication in stressed cells: evidence from Escherichia coliJ M Moore, Hallie Wimberly, P C Thornton, et al.
Nature Communications|July 6, 2013
R-loops and nicks initiate DNA breakage and genome instability in non-growing Escherichia coliHallie Wimberly, Chandan Shee, P C Thornton, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitisJ R B Green, J C Mansfield, J A Gibson, et al.
Journal of Bacteriology|July 20, 2010
Separate DNA Pol II- and Pol IV-dependent pathways of stress-induced mutation during double-strand-break repair in Escherichia coli are controlled by RpoSRyan L Frisch, Yang Su, P C Thornton, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitisJ C Mansfield, M H Giaffer, P A Cann, et al.
Plos Genetics|September 9, 2011
Global chromosomal structural instability in a subpopulation of starving Escherichia coli cellsDongxu Lin, Ian B Gibson, Jessica M Moore, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1980
Carbenoxolone interactions in man--preliminary reportP C Thornton, M Papouchado, P I Reed
Laboratory Animals|April 1, 1979
The ferret, Mustela putorius furo, as a new species in toxicologyP C Thornton, P A Wright, P J Sacra, et al.
Plos Genetics|April 11, 2006
On the mechanism of gene amplification induced under stress in Escherichia coliAndrew Slack, P C Thornton, Daniel B Magner, et al.
Annals of the New York Academy of Sciences|September 8, 2012
Gross chromosomal rearrangement mediated by DNA replication in stressed cells: evidence from Escherichia coliJ M Moore, Hallie Wimberly, P C Thornton, et al.
Nature Communications|July 6, 2013
R-loops and nicks initiate DNA breakage and genome instability in non-growing Escherichia coliHallie Wimberly, Chandan Shee, P C Thornton, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitisJ R B Green, J C Mansfield, J A Gibson, et al.
Journal of Bacteriology|July 20, 2010
Separate DNA Pol II- and Pol IV-dependent pathways of stress-induced mutation during double-strand-break repair in Escherichia coli are controlled by RpoSRyan L Frisch, Yang Su, P C Thornton, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2002
A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitisJ C Mansfield, M H Giaffer, P A Cann, et al.
Plos Genetics|September 9, 2011
Global chromosomal structural instability in a subpopulation of starving Escherichia coli cellsDongxu Lin, Ian B Gibson, Jessica M Moore, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Patient-led variable dosing with balsalazide as long-term therapy for maintenance in ulcerative colitis: a 3-year prospective observational studyJ R B Green, C H J Swan, J A Gibson, et al.
Pageof 2